POST-PLATINUM TREATMENT LANDSCAPE IN PATIENTS WITH RECURRENT ENDOMETRIAL CANCER: ANALYSIS OF GERMAN CLAIMS DATA

被引：0
|
作者：
Mevius, A. [1 ]
Link, T. [2 ,3 ]
Welte, R. [4 ]
Wacker, M. [4 ]
Wilke, T. [1 ]
Karl, F. [4 ]
机构：
[1] Inst Pharmakook & Arzneimittell eV IPAM, Wismar, Germany
[2] Univ Klikum Carl Gustav Carus Dresden, Dept Gynecol & Obstet, Dresden, Germany
[3] Tech Univ Dresden, Dresden, Germany
[4] GlaxoSmithKline GmbH & Co KG, Prinzregentenpl, Munich, Germany
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2021年 / 31卷
关键词：
D O I：
10.1136/ijgc-2021-ESGO.111
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
73
引用
收藏
页码：A72 / A73
页数：4
相关论文
共 50 条
  • [1] Real-world treatment of German patients with recurrent and advanced endometrial cancer with a post-platinum treatment: a retrospective claims data analysis
    Mevius, Antje
    Karl, Florian
    Wacker, Margarethe
    Welte, Robert
    Krenzer, Stefanie
    Link, Theresa
    Maywald, Ulf
    Wilke, Thomas
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (05) : 1929 - 1939
  • [2] Real-world treatment of German patients with recurrent and advanced endometrial cancer with a post-platinum treatment: a retrospective claims data analysis
    Antje Mevius
    Florian Karl
    Margarethe Wacker
    Robert Welte
    Stefanie Krenzer
    Theresa Link
    Ulf Maywald
    Thomas Wilke
    [J]. Journal of Cancer Research and Clinical Oncology, 2023, 149 : 1929 - 1939
  • [3] Outcomes of dostarlimab versus chemotherapy in post-platinum patients with recurrent/advanced endometrial cancer: data from the GARNET trial and the National Cancer Registration Service in England
    Goulden, Scott
    Heffernan, Kiera
    Sen Nikitas, Fulya
    Shukla, Urmi
    Knott, Craig
    Hunger, Matthias
    Pahwa, Ankit
    Schade, Rene
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 (11) : 1715 - 1723
  • [4] THERAPY CHOICE AND COST OF CARE IN PATIENTS WITH ADVANCED OR RECURRENT ENDOMETRIAL CANCER PREVIOUSLY TREATED WITH PLATINUM-BASED THERAPY: ANALYSIS OF US CLAIMS DATA
    Pothuri, B.
    Perhanidis, J.
    Gibson, C. J.
    Brown, J.
    [J]. VALUE IN HEALTH, 2019, 22 : S38 - S38
  • [5] BIG DATA ANALYSIS OF CANCER TREATMENT IN GERMANY - MAPPING OF TREATMENT LANDSCAPE BASED ON A GERMAN STATUTORY HEALTH INSURANCE (SHI) CLAIMS DATA ANALYSIS
    May, M.
    Schellong, S.
    Bruchhausen, Y.
    Kretzschmar, A.
    Riess, H.
    [J]. VALUE IN HEALTH, 2018, 21 : S64 - S64
  • [6] INCIDENCE AND TREATMENT OF PATIENTS WITH STATUS EPILEPTICUS: AN ANALYSIS OF GERMAN CLAIMS DATA
    Groth, A.
    Foskett, N.
    Gille, P.
    Joeres, L.
    Wilke, T.
    Rosenow, F.
    Strzelczyk, A.
    [J]. VALUE IN HEALTH, 2018, 21 : S332 - S332
  • [7] Prolonged treatment of patients with cancer associated thromboembolism (CAT). mapping of treatment landscape based on a German statutory health insurance (SHI) claims data analysis [CERTIFICAT]
    Kretzschmar, Albrecht
    May, Melanie
    Heinken, Andreas
    Riess, Hanno
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [8] Anticoagulant treatment of patients with cancer associated thromboembolism (CAT). Mapping of treatment landscape based on a German Statutory Health Insurance (SHI) claims data analysis [CERTIFICAT]
    Heinken, A.
    Kretzschmar, A.
    May, M.
    Riess, H.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 216 - 216
  • [9] Outcomes for Dostarlimab and Real-World Treatments in Post-platinum Patients With Advanced or Recurrent Endometrial Cancer: The GARNET Trial Versus a US Electronic Health Record-based Control Arm
    Goulden, Scott
    Shen, Qin
    Coleman, Robert L.
    Mathews, Cara
    Hunger, Matthias
    Pahwa, Ankit
    Schade, Rene
    [J]. JOURNAL OF HEALTH ECONOMICS AND OUTCOMES RESEARCH, 2023, 10 (02): : 53 - 61
  • [10] Real-world data on dostarlimab in post-platinum mismatch repair deficient (dMMR)/ microsatellite instability high (MSI-H) advanced/recurrent (A/R) endometrial cancer: Descriptive analysis of the French cohort temporary authorization of use (ATU)
    Rodrigues, M. J.
    Eberst, L.
    Follana, P.
    Brunel, V.
    Gauthier, L.
    Jacquemin, V. J.
    Tessier, C.
    El Mouaddin, N.
    Boudier, P.
    Fiteni, F.
    Angeli, E.
    Roche, S.
    Bonnet, I.
    Deldycke, C.
    Delanoy, N.
    Sabatier, R.
    Flippot, R.
    Rouge, T. De la Motte
    [J]. ANNALS OF ONCOLOGY, 2022, 33 (07) : S801 - S802
12345